Company Filing History:
Years Active: 2008
Title: Johannes Joseph De Haard: Innovator in Antibody Technology
Introduction
Johannes Joseph De Haard is a notable inventor based in the Netherlands. He has made significant contributions to the field of antibody technology, particularly in the development of humanized antibodies and binding molecules. His innovative work has implications for therapeutic applications and the advancement of medical science.
Latest Patents
De Haard's latest patents include the "Camelid Antibody Platform For Generating Humanized Antibodies." This patent focuses on humanized antibodies derived from the conventional antibody repertoire of species in the family Camelidae. The invention provides an antibody that comprises a camelid VH domain and a camelid VL domain, characterized by at least one humanizing amino acid substitution in the VH domain and/or the VL domain. Another significant patent is "Binding Molecules With Multiple Binding Sites, Compositions Comprising The Same And Uses Thereof." This invention relates to binding molecules, such as amino acid sequences with multiple antigen binding sites, which can inhibit or block interactions between naturally occurring binding molecules.
Career Highlights
Throughout his career, De Haard has worked with prominent companies in the biotechnology sector, including Ablynx N.V. and Argenx Bvba. His experience in these organizations has allowed him to refine his expertise in antibody development and contribute to groundbreaking research.
Collaborations
De Haard has collaborated with notable professionals in his field, including Edward Dolk and Michael John Saunders. These collaborations have further enhanced his work and contributed to advancements in antibody technology.
Conclusion
Johannes Joseph De Haard is a distinguished inventor whose work in antibody technology has the potential to impact therapeutic applications significantly. His innovative patents and collaborations reflect his commitment to advancing medical science through research and development.